265 related articles for article (PubMed ID: 22784486)
1. Effects of ketamine in treatment-refractory obsessive-compulsive disorder.
Bloch MH; Wasylink S; Landeros-Weisenberger A; Panza KE; Billingslea E; Leckman JF; Krystal JH; Bhagwagar Z; Sanacora G; Pittenger C
Biol Psychiatry; 2012 Dec; 72(11):964-70. PubMed ID: 22784486
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.
Rodriguez CI; Kegeles LS; Levinson A; Feng T; Marcus SM; Vermes D; Flood P; Simpson HB
Neuropsychopharmacology; 2013 Nov; 38(12):2475-83. PubMed ID: 23783065
[TBL] [Abstract][Full Text] [Related]
3. Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.
Luckenbaugh DA; Ibrahim L; Brutsche N; Franco-Chaves J; Mathews D; Marquardt CA; Cassarly C; Zarate CA
Bipolar Disord; 2012 Dec; 14(8):880-7. PubMed ID: 22978511
[TBL] [Abstract][Full Text] [Related]
4. Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review.
Alves-Pereira R; Fontes M; Cordeiro V; Bandeira ID; Faria-Guimarães D; Silva SS; Mello RP; Leal GC; Sampaio AS; Quarantini LC
Clin Neuropharmacol; 2024 Jan-Feb 01; 47(1):17-21. PubMed ID: 38194244
[TBL] [Abstract][Full Text] [Related]
5. Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder.
Niciu MJ; Grunschel BD; Corlett PR; Pittenger C; Bloch MH
J Psychopharmacol; 2013 Jul; 27(7):651-4. PubMed ID: 23676198
[TBL] [Abstract][Full Text] [Related]
6. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
[TBL] [Abstract][Full Text] [Related]
7. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
Feusner JD; Kerwin L; Saxena S; Bystritsky A
Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
[TBL] [Abstract][Full Text] [Related]
8. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA
J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547
[TBL] [Abstract][Full Text] [Related]
9. Ketamine induces immediate and delayed alterations of OCD-like behavior.
Thompson SL; Welch AC; Iourinets J; Dulawa SC
Psychopharmacology (Berl); 2020 Mar; 237(3):627-638. PubMed ID: 31927606
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
[TBL] [Abstract][Full Text] [Related]
11. An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder.
Grant P; Lougee L; Hirschtritt M; Swedo SE
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):761-7. PubMed ID: 18315448
[TBL] [Abstract][Full Text] [Related]
12. In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.
Rodriguez CI; Kegeles LS; Levinson A; Ogden RT; Mao X; Milak MS; Vermes D; Xie S; Hunter L; Flood P; Moore H; Shungu DC; Simpson HB
Psychiatry Res; 2015 Aug; 233(2):141-7. PubMed ID: 26104826
[TBL] [Abstract][Full Text] [Related]
13. Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.
Duncan WC; Selter J; Brutsche N; Sarasso S; Zarate CA
J Affect Disord; 2013 Feb; 145(1):115-9. PubMed ID: 22871531
[TBL] [Abstract][Full Text] [Related]
14. Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects.
Lepow L; Luckenbaugh DA; Park L; Henter ID; Zarate CA
J Psychiatr Res; 2017 Mar; 86():55-57. PubMed ID: 27914292
[No Abstract] [Full Text] [Related]
15. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
[TBL] [Abstract][Full Text] [Related]
16. Intravenous ketamine therapy in a patient with a treatment-resistant major depression.
Liebrenz M; Borgeat A; Leisinger R; Stohler R
Swiss Med Wkly; 2007 Apr; 137(15-16):234-6. PubMed ID: 17525879
[TBL] [Abstract][Full Text] [Related]
17. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Diazgranados N; Ibrahim L; Brutsche NE; Newberg A; Kronstein P; Khalife S; Kammerer WA; Quezado Z; Luckenbaugh DA; Salvadore G; Machado-Vieira R; Manji HK; Zarate CA
Arch Gen Psychiatry; 2010 Aug; 67(8):793-802. PubMed ID: 20679587
[TBL] [Abstract][Full Text] [Related]
18. Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder.
Rodriguez CI; Kegeles LS; Flood P; Simpson HB
J Clin Psychiatry; 2011 Apr; 72(4):567-9. PubMed ID: 21527129
[No Abstract] [Full Text] [Related]
19. Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.
Glue P; Medlicott NJ; Harland S; Neehoff S; Anderson-Fahey B; Le Nedelec M; Gray A; McNaughton N
J Psychopharmacol; 2017 Oct; 31(10):1302-1305. PubMed ID: 28441895
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant effects of ketamine in depressed patients.
Berman RM; Cappiello A; Anand A; Oren DA; Heninger GR; Charney DS; Krystal JH
Biol Psychiatry; 2000 Feb; 47(4):351-4. PubMed ID: 10686270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
